Target: IL-1 Beta Generic name: Canakinumab Product Origin: Recombinant in CHO cells Canakinumab is a recombinant, human anti-human-IL-1betamonoclonal antibody that belongs to the IgG1/kappa isotype subclass with a molecular mass of 145157 Daltons when d
Purity: >98.0% as determined by SEC-HPLC & SDS-PAGE.
Form:
Purified
Antibody Type:
Recombinant Antibody
Application Dilute:
Specificity: Human IL1 beta. Does not cross react with other members of the interleukin-1 family. Inquire for more than 1 mg quantities. Availability 5-7 weeks.
* VAT and and shipping costs not included. Errors and price changes excepted